Go to:
Logótipo
Você está em: Start > Fernando Fernandez-Llimos

Fernando Fernandez-Llimos

Fotografia de Fernando Fernandez-Llimos Somoza
Name: Fernando Fernandez-Llimos Somoza
Sigla: FFL
Estado: Active
R-000-QJ9
0000-0002-8529-9595
F716-B3AD-341A
B-8931-2008
56366491700
Email Institucional: fllimos@ff.up.pt
Extensão Telefónica: 8606
Salas: E3 | S30.P4.E3

Funções

Categoria: Professor Auxiliar
Carreira: Pessoal Docente de Universidades
Professional Group: Docente
Department / I&D Unit: Drug Sciences Department
Laboratory/Services Provision Unit: Pharmacology Laboratory

Cargos

Cargo Data de Início
Member of the Scientific Board 2024-05-23

Apresentação Pessoal

Fernando Fernandez-Llimos is professor at the Laboratory of Pharmacology, Department of Drug Sciences at the Faculty of Pharmacy, University of Porto, and integrated member of the UCIBIO - Research Unit on Applied Molecular Biosciences.

Fernando Fernandez-Llimos graduated in Pharmaceutical Sciences by the Complutense University (Madrid, Spain) and obtained his PhD in Drug Research and Development with focus on Drug Information by the University of Granada (Spain). He also obtained Master in Sciences degrees by the University of Santiago de Compostela, the University of Valencia, and a MBA by the Vigo Business School. He obtained the Habilitation in 2019 by the University of Lisbon (Portugal), where he was professor and member of the Institute for Medicines Research (iMed.ULisboa) for 12 years.

His research interests are about drug information, with special emphasis on evidence synthesis, and in design and assessing clinical pharmacy services. He shares these interests with a passion by the sea, being scuba diver instructor and sailing skipper.

Áreas de Interesse

  1. Health sciences > Pharmacological sciences > Pharmacy
  2. Health sciences > Pharmacological sciences > Clinical pharmacology
Recommend this page Top
Copyright 1996-2024 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-10-18 at 18:29:48 | Acceptable Use Policy | Data Protection Policy | Complaint Portal